Business Description
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.39 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.79 | |||||
Debt-to-EBITDA | 4.9 | |||||
Interest Coverage | 1.28 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.85 | |||||
Beneish M-Score | -2.61 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.5 | |||||
3-Year EBITDA Growth Rate | 5.3 | |||||
3-Year FCF Growth Rate | -24.6 | |||||
3-Year Book Growth Rate | 12.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.67 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -36.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.48 | |||||
Quick Ratio | 1.06 | |||||
Cash Ratio | 0.64 | |||||
Days Inventory | 104.86 | |||||
Days Sales Outstanding | 46.52 | |||||
Days Payable | 61.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Payout Ratio | 48.17 | |||||
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | 16.06 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 32.56 | |||||
Operating Margin % | 3.21 | |||||
Net Margin % | -0.29 | |||||
FCF Margin % | 3.03 | |||||
ROE % | -0.3 | |||||
ROA % | -0.14 | |||||
ROIC % | -3.92 | |||||
ROC (Joel Greenblatt) % | 4.45 | |||||
ROCE % | 1.52 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 20.33 | |||||
PE Ratio without NRI | 41.37 | |||||
Price-to-Owner-Earnings | 17.95 | |||||
PS Ratio | 0.86 | |||||
PB Ratio | 0.83 | |||||
Price-to-Tangible-Book | 6.11 | |||||
Price-to-Free-Cash-Flow | 28.25 | |||||
Price-to-Operating-Cash-Flow | 5.9 | |||||
EV-to-EBIT | 48.37 | |||||
EV-to-Forward-EBIT | 12.09 | |||||
EV-to-EBITDA | 8.14 | |||||
EV-to-Forward-EBITDA | 6.96 | |||||
EV-to-Revenue | 1.26 | |||||
EV-to-Forward-Revenue | 1.57 | |||||
EV-to-FCF | 41.69 | |||||
Earnings Yield (Greenblatt) % | 2.07 | |||||
FCF Yield % | 3.8 | |||||
Forward Rate of Return (Yacktman) % | 3.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MDMXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medmix AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 545.645 | ||
EPS (TTM) ($) | 0.012 | ||
Beta | 0 | ||
Volatility % | 26.09 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 17.4 | ||
12-1 Month Momentum % | -36.47 | ||
52-Week Range ($) | 17.4 - 27.39 | ||
Shares Outstanding (Mil) | 40.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medmix AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medmix AG Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Medmix AG Frequently Asked Questions
What is Medmix AG(MDMXF)'s stock price today?
When is next earnings date of Medmix AG(MDMXF)?
Does Medmix AG(MDMXF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |